PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Repertoire Immune Medicines, Cambridge, MA, USA.\', \'Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.\', \'Division of Biological Sciences, Molecular Biology Section, University of California, San Diego, San Diego, CA, USA.\', \'Department of Chemistry and Koch Institute for Integrative Cancer Research, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Broad Institute of MIT and Harvard, Cambridge, MA, USA.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.\', \'Department of Immunology, Harvard Medical School, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/sciimmunol.abk3070
?:doi
?:hasPublicationType
?:journal
  • Science immunology
is ?:pmid of
?:pmid
?:pmid
  • 34793243
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all